APA (7th ed.) Citation

KG, F., & JS, S. (2024). Ambroxol Improves Amyloidogenic, NF-κB, and Nrf2 Pathways in a Scopolamine-Induced Cognitive Impairment Rat Model of Alzheimer's Disease. Drug development research, 85(7), e70017. https://doi.org/10.1002/ddr.70017

Chicago Style (17th ed.) Citation

KG, Faldu, and Shah JS. "Ambroxol Improves Amyloidogenic, NF-κB, and Nrf2 Pathways in a Scopolamine-Induced Cognitive Impairment Rat Model of Alzheimer's Disease." Drug Development Research 85, no. 7 (2024): e70017. https://doi.org/10.1002/ddr.70017.

MLA (9th ed.) Citation

KG, Faldu, and Shah JS. "Ambroxol Improves Amyloidogenic, NF-κB, and Nrf2 Pathways in a Scopolamine-Induced Cognitive Impairment Rat Model of Alzheimer's Disease." Drug Development Research, vol. 85, no. 7, 2024, p. e70017, https://doi.org/10.1002/ddr.70017.